|
|
Blood, 15 April 2006, Vol. 107, No. 8, pp. 3034-3044.
Prepublished online as a Blood First Edition Paper on January 5, 2006; DOI 10.1182/blood-2005-09-3679.
Previous Article | Table of Contents | Next Article 
REVIEW ARTICLES
Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation
Felipe Suarez,
Olivier Lortholary,
Olivier Hermine, and
Marc Lecuit
From the Department of Hematology and the Department of Infectious Diseases, Assistance Publique des Hôpitaux de Paris (AP-HP) Necker-Enfants Malades Hospital, René DescartesParis 5 University Medical School, Paris, France; the Molecular Mycology Unit, Centre National de la Recherche Scientifique (CNRS) Formation de Recherche en Evolution (FRE) 2849, and Avenir group U604, Institut National de la Santé et de la Recherche Médicale (INSERM) U604, Institut Pasteur, Paris, France; and CNRS Unite Mixté de Recherche (UMR) 8603, Institut Fédératif de Recherche (IFR) 94, René DescartesParis 5 University Medical School, Paris, France.
Non-Hodgkin lymphomas develop from nodal and extranodal lymphoid tissues. A distinct subset of extranodal lymphomas arising from B cells of the marginal zone (MZ) of mucosa-associated lymphoid tissue (MALT) or spleen has been individualized. Growing evidence indicates that MZ lymphomas are associated with chronic antigenic stimulation by microbial pathogens and/or autoantigens. The list of microbial species associated with MZ lymphoproliferations has grown longer with molecular investigations and now comprises at least 5 distinct members: H pylori, C jejuni, B burgdorferi, C psittaci, and hepatitis C virus (HCV), which have been associated with gastric lymphoma, immunoproliferative small intestinal disease, cutaneous lymphoma, ocular lymphoma, and spleen lymphoma, respectively. A pathophysiologic scenario involving chronic and sustained stimulation of the immune system leading to lymphoid transformation has emerged. It defines a distinct category of infection-associated lymphoid malignancies, in which the infectious agent does not directly infect and transform lymphoid cells, as do the lymphotropic oncogenic viruses Epstein-Barr virus (EBV), human herpesvirus 8 (HHV8), and human T-lymphotropic virus 1 (HTLV-1), but rather indirectly increases the probability of lymphoid transformation by chronically stimulating the immune system to maintain a protracted proliferative state.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Schollkopf, M. Melbye, L. Munksgaard, K. E. Smedby, K. Rostgaard, B. Glimelius, E. T. Chang, G. Roos, M. Hansen, H.-O. Adami, et al.
Borrelia infection and risk of non-Hodgkin lymphoma
Blood,
June 15, 2008;
111(12):
5524 - 5529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. M L Cohen, J. Sweetenham, and A. D Singh
Ocular adnexal lymphoma. What is the evidence for an infectious aetiology?
Br. J. Ophthalmol.,
April 1, 2008;
92(4):
446 - 448.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Portlock, P. Hamlin, A. Noy, W. Chey, C. A. Gaydos, L. Palomba, I. Schwartz, S. Corcoran, L. Rosenzweig, D. Walker, et al.
Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy
Ann. Onc.,
February 1, 2008;
19(2):
254 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. de Boer, R. F. Hiddink, M. Raderer, N. Antonini, B. M. P. Aleman, H. Boot, and D. de Jong
Dissemination patterns in non-gastric MALT lymphoma
Haematologica,
February 1, 2008;
93(2):
201 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Morton, O. Landgren, N. Chatterjee, D. Castenson, R. Parsons, R. N. Hoover, and E. A. Engels
Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients
Blood,
December 15, 2007;
110(13):
4599 - 4605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bianchettin, C. Bonaccini, R. Oliva, A. Tramontano, A. Cividini, M. Casato, G. Merlini, E. Silini, and M. U. Mondelli
Analysis of Hepatitis C Virus Hypervariable Region 1 Sequence from Cryoglobulinemic Patients and Associated Controls
J. Virol.,
May 1, 2007;
81(9):
4564 - 4571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Engels
Infectious Agents as Causes of Non-Hodgkin Lymphoma
Cancer Epidemiol. Biomarkers Prev.,
March 1, 2007;
16(3):
401 - 404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Arnaud, M-C Escande, M Lecuit, P Validire, C Levy, C Plancher, A Vincent-Salomon, N Brousse, P de Cremoux, O Hermine, et al.
Hepatitis C virus infection and MALT-type ocular adnexal lymphoma
Ann. Onc.,
February 1, 2007;
18(2):
400 - 401.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Arcaini, S Burcheri, A Rossi, M Paulli, R Bruno, F Passamonti, E Brusamolino, A Molteni, A Pulsoni, M. Cox, et al.
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
Ann. Onc.,
February 1, 2007;
18(2):
346 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Florins, N. Gillet, B. Asquith, C. Debacq, G. Jean, I. Schwartz-Cornil, M. Bonneau, A. Burny, M. Reichert, R. Kettmann, et al.
Spleen-Dependent Turnover of CD11b Peripheral Blood B Lymphocytes in Bovine Leukemia Virus-Infected Sheep
J. Virol.,
December 15, 2006;
80(24):
11998 - 12008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Halfdanarson, S. Markovic, U Kalokhe, and M Luppi
A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy
Ann. Onc.,
December 1, 2006;
17(12):
1849 - 1850.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. I. Bussiere, R. Chaturvedi, M. Asim, K. L. Hoek, Y. Cheng, J. Gainor, A. Scholz, W. N. Khan, and K. T. Wilson
Low Multiplicity of Infection of Helicobacter pylori Suppresses Apoptosis of B Lymphocytes.
Cancer Res.,
July 1, 2006;
66(13):
6834 - 6842.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |